Amid a surge in drug-resistant bacteria, researchers believe they have discovered a new class of antibiotics for the first ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Pathogen causes severe disease and poses significant challenges to global public health, with an urgent need for continuous ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks ...

They found a new molecule named lariocidin —a potential new antibiotic with the power to kill some of the world’s most ...

Lariocidin is a newly discovered antibiotic from soil bacteria. It targets the bacterial ribosome, defeating resistant ...

The virulent strain of antibiotic-resistant microbes causes severe disease, posing significant challenges to global public ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The project will prompt doctors to prescribe more safely, to reduce the looming risk of antimicrobial resistance, which one ...

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...